PHOTO - (From left) Dr Sam Mohan, regional director of Agilent Life Sciences Group, Southeast Asia; Rod Minett, general manager of Agilent Life Sciences Group, South Asia Pacific and Korea; Professor Robin Pollard, president and pro vice-chancellor of Monash University Sunway campus; Professor Dato' Dr Anuar Zaini Md Zain, head, the Jeffrey Cheah School of Medicine and Health Sciences of Monash University Sunway campus.
Global measurements firm Agilent Technologies has collaborated with Monash University Sunway in Malaysia to form a centre of excellence intended to enhance genomics research into diabetes, cancer, neurobiology, and infectious diseases.
Under the agreement, the centre of excellence - the Monash-Agilent Authorised Microarray Service Centre (AMSC) - will be equipped with the latest microarray instruments and will provide competency training for the centre's lab professionals, said Professor Dato' Dr Anuar Zaini Md Zain, the head of Jeffrey Cheah School of Medicine and Health Sciences of Monash University Sunway in mid-December 2011.
"The establishment of the AMSC will be a timely boost in the collaboration between Agilent and Monash University Sunway campus through the Jeffrey Cheah School of Medicine and Health Sciences, providing the opportunity to access advanced technologies to strengthen our current genomics research in diabetes, cancer, neurobiology and infectious diseases," said Prof Anuar.
"The collaboration between Agilent and Monash University Sunway would include knowledge-sharing between both organisations, including real-time communication of new developments in the field of microarray applications as well as networking with Agilent's global customers who are shaping the future of genomics," he said.
"The AMSC, together with existing platform technologies at the school, such as liquid chromatography/mass spectrometry and proteomics, will encourage integrative and multi-disciplinary research," said Prof Anuar. "The centre will become the platform to train next-generation scientists in genomics research and potentially spearhead new niche areas in biomedical research through support and networking with Agilent's global customers/collaborators."
Genomics is the study of all genes of an organism, and DNA microarrays enable the measurement of multiple molecular changes to genes. These changes can reveal the molecular basis of diseases, enabling scientists to discover and develop new methods of treatment for these diseases.
Cementing Malaysia as a centre for life sciences research
"We are excited about this collaboration with Monash University Sunway campus," said Agilent Life Sciences Group, general manager, South Asia Pacific and Korea, Rod Minett. "The knowledge gleaned from the collaboration will not only contribute towards further understanding and preventing diseases, but also cement Malaysia as a centre for life sciences research and development."
Sign up for CIO Asia eNewsletters.